{
"id":"mk19_bb_nr_s5",
"subspecialtyId":"nr",
"title":"Ischemic Stroke and Transient Ischemic Attack",
"jsonContent":{
"type":"section",
"id":"mk19_bb_nr_s5",
"title":{
"__html":"Ischemic Stroke and Transient Ischemic Attack"
},
"titleNode":{
"type":"section-title",
"hlId":"0e3e28",
"children":[
"Ischemic Stroke and Transient Ischemic Attack"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_nr_s5_1",
"title":{
"__html":"Prevention"
},
"titleNode":{
"type":"section-title",
"hlId":"c53b76",
"children":[
"Prevention"
]
},
"children":[
{
"type":"p",
"hlId":"3e4f67",
"children":[
"Risk factor modification is mandatory for all patients (diabetes, hypertension, hyperlipidemia, tobacco use)."
]
},
{
"type":"p",
"hlId":"7071a4",
"children":[
"Begin warfarin or a ",
{
"type":"abbreviation",
"title":"direct oral anticoagulant",
"children":[
"DOAC"
]
},
" in most patients with nonvalvular ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"atrial fibrillation",
"children":[
"AF"
]
},
"."
]
}
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"5ed1ea",
"children":[
"Warfarin is the only approved drug for valvular AF."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_nr_s5_2",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"4db6b9",
"children":[
"Stroke is a sudden focal neurologic deficit caused by ischemia (85%) or hemorrhage (15%). Ischemic stroke may be further characterized by the causative mechanism (large artery atherosclerosis, cardioembolic stroke, small-vessel disease, embolic stroke of undetermined source). Hemorrhagic stroke is classified as either subarachnoid or intracerebral."
]
},
{
"type":"p",
"hlId":"eea806",
"children":[
{
"type":"abbreviation",
"title":"transient ischemic attack",
"children":[
"TIA"
]
},
" is a transient focal neurologic deficit resulting from ischemia rather than infarction. TIA is defined by the absence of infarction on neuroimaging, independent of symptom duration."
]
},
{
"type":"p",
"hlId":"8b37ad",
"children":[
" ",
{
"type":"alert",
"children":[
"All patients with stroke or TIA require:"
]
},
" "
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"ea7ae0",
"children":[
" ",
{
"type":"alert",
"children":[
"emergent head CT without contrast (to rule out intracranial hemorrhage)"
]
},
" "
]
},
" ",
{
"type":"list-item",
"hlId":"ba98ca",
"children":[
" ",
{
"type":"alert",
"children":[
{
"type":"abbreviation",
"title":"electrocardiogram",
"children":[
"ECG"
]
},
" and telemetry (to rule out AF)"
]
},
" "
]
},
" ",
{
"type":"list-item",
"hlId":"5a3a6c",
"children":[
{
"type":"alert",
"children":[
"duplex ultrasonography of internal carotid artery;"
]
},
" ",
{
"type":"abbreviation",
"title":"magnetic resonance angiography",
"children":[
"MRA"
]
},
" and ",
{
"type":"abbreviation",
"title":"computed tomography angiography",
"children":[
"CTA"
]
},
" are appropriate confirmatory tests"
]
},
" ",
{
"type":"list-item",
"hlId":"3a8a62",
"children":[
" ",
{
"type":"alert",
"children":[
"echocardiography (to rule out ",
{
"type":"abbreviation",
"title":"left ventricular",
"children":[
"LV"
]
},
" or valvular thrombus)"
]
},
" "
]
},
" "
]
},
{
"type":"p",
"hlId":"998d7b",
"children":[
"Patients with TIA have an elevated risk for subsequent stroke, particularly in the next 48 hours. The decision to hospitalize patients is based on risk stratification."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"4bbb92",
"children":[
"Routine evaluation for thrombophilia is not indicated for patients with TIA or stroke."
]
},
" ",
{
"type":"list-item",
"hlId":"0d2050",
"children":[
"Patients with suspected cardioembolic stroke should undergo prolonged cardiac rhythm monitoring to rule out AF."
]
},
" ",
{
"type":"list-item",
"hlId":"a6175f",
"children":[
"Consider vertebrobasilar stroke in older adults with persistent, acute-onset vertigo."
]
},
" ",
{
"type":"list-item",
"hlId":"9fbea8",
"children":[
"The routine use of ",
{
"type":"abbreviation",
"title":"transesophageal echocardiography",
"children":[
"TEE"
]
},
" to evaluate the source of stroke is not indicated."
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_nr_s5_3",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"443d3a",
"children":[
"Select intubation and mechanical ventilation for patients with a decreased level of consciousness."
]
},
{
"type":"p",
"hlId":"6201eb",
"children":[
{
"type":"alert",
"children":[
"Administer ",
{
"type":"abbreviation",
"title":"recombinant tissue plasminogen activator",
"children":[
"rtPA"
]
},
" to all patients with ischemic stroke within 3 hours of stroke onset (if unknown onset, then within 3 hours of the last time the patient was seen to be well)."
]
},
" rtPA may rarely be administered up to 4.5 hours after onset in selected patients who do not possess any of the following exclusionary criteria:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"5e7c53",
"children":[
"age >80 years"
]
},
" ",
{
"type":"list-item",
"hlId":"5e0fe8",
"children":[
"severe stroke"
]
},
" ",
{
"type":"list-item",
"hlId":"3be35d",
"children":[
"diabetes mellitus with a previous infarct"
]
},
" ",
{
"type":"list-item",
"hlId":"b5319b",
"children":[
"anticoagulant use"
]
},
" "
]
},
{
"type":"p",
"hlId":"c36636",
"children":[
"Exclusionary criteria for thrombolysis in general include any increased risk for bleeding, diagnosis of ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"intracerebral hemorrhage",
"children":[
"ICH"
]
},
","
]
},
" recent head trauma, stroke (before current stroke), cranial surgery, or ",
{
"type":"alert",
"children":[
{
"type":"abbreviation",
"title":"systolic blood pressure",
"children":[
"SBP"
]
},
" >185 mm Hg and ",
{
"type":"abbreviation",
"title":"diastolic blood pressure",
"children":[
"DBP"
]
},
" >110 mm Hg despite treatment"
]
},
"."
]
},
{
"type":"p",
"hlId":"a0e33b",
"children":[
"In patients with suspicion of a thrombolysis-induced intracranial hemorrhage manifesting as neurologic deterioration, stop ongoing infusion of rtPA and evaluate with another CT."
]
},
{
"type":"p",
"hlId":"5f4aa5",
"children":[
"Additional therapy in patients with stroke:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"7e5b8d",
"children":[
"acetaminophen for temperature >38.0 °C (100.4 °F)"
]
},
" ",
{
"type":"list-item",
"hlId":"2a24e7",
"children":[
"normal saline to maintain euvolemia"
]
},
" ",
{
"type":"list-item",
"hlId":"39a402",
"children":[
"aspirin (unless thrombolysis is planned)"
]
},
" ",
{
"type":"list-item",
"hlId":"71e672",
"children":[
{
"type":"abbreviation",
"title":"deep venous thrombosis",
"children":[
"DVT"
]
},
" prophylaxis initiation within 48 hours"
]
},
" "
]
},
{
"type":"p",
"hlId":"e5d4ce",
"children":[
"Do not begin antihypertensive treatment within the first 48 hours unless:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"3f2115",
"children":[
"SBP is >220 mm Hg, DBP is >120 mm Hg"
]
},
" ",
{
"type":"list-item",
"hlId":"9d607a",
"children":[
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"acute coronary syndrome",
"children":[
"ACS"
]
},
","
]
},
" aortic dissection, or end-organ damage is present"
]
},
" "
]
},
{
"type":"p",
"hlId":"9cf784",
"children":[
"If the patient is eligible for thrombolysis, ",
{
"type":"abbreviation",
"title":"blood pressure",
"children":[
"BP"
]
},
" must be lowered to <180 mm Hg systolic and <105 mm Hg diastolic and maintained below these levels for at least 24 hours after therapy. Preferred antihypertensive agents include IV labetalol and IV nicardipine."
]
},
{
"type":"p",
"hlId":"280913",
"children":[
"A swallowing assessment is recommended for patients with stroke before they start to eat, drink, or take oral medications. Early stroke rehabilitation improves clinical outcomes."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_nr_s5_inline_t1"
],
"forceOpen":true
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"ec715a",
"children":[
"If the patient is unable to report the time of onset, and no other person witnessed the onset, rtPA treatment is contraindicated."
]
},
" ",
{
"type":"list-item",
"hlId":"689a1a",
"children":[
"Do not select heparin for most patients with ischemic stroke."
]
},
" ",
{
"type":"list-item",
"hlId":"a611d1",
"children":[
"Do not select anticonvulsant medications after stroke unless the patient has had a seizure."
]
},
" ",
{
"type":"list-item",
"hlId":"337a57",
"children":[
"Do not select carotid endarterectomy for 100% carotid artery stenosis"
]
},
" "
]
},
{
"type":"inline-wrap",
"wrapId":"2",
"contentIds":[
"mk19_bb_nr_f05"
],
"forceOpen":true
}
]
}
]
},
"tablesContent":{
"mk19_bb_nr_s5_inline_t1":{
"id":"mk19_bb_nr_s5_inline_t1",
"number":1,
"bookId":"nr",
"title":{
"__html":"Study Table: Secondary Prevention of Stroke"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"51b705",
"children":[
"Study Table: Secondary Prevention of Stroke"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c143a2",
"class":"col hd l",
"children":[
"Intervention"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"1b1583",
"class":"col hd l",
"children":[
"Indication"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ee19b4",
"class":"cell txt l",
"children":[
"Antiplatelet therapy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"057ba1",
"class":"cell txt l",
"children":[
"In the acute setting, begin aspirin immediately or within 24 hours after giving thrombolytic agents."
]
},
" ",
{
"type":"p",
"hlId":"6027ff",
"class":"cell txt l",
"children":[
"In the chronic setting (>90 days after stroke), aspirin is reasonable monotherapy; aspirin plus dipyridamole is slightly superior to aspirin alone. Clopidogrel is equivalent to aspirin and dipyridamole."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"64961b",
"class":"cell txt l",
"children":[
"Anticoagulation therapy"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"7802b2",
"class":"cell txt l",
"children":[
"After 48 hours, treat cardioembolic causes of stroke and TIA with warfarin (valvular atrial fibrillation) or a DOAC (nonvalvular atrial fibrillation)."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6996f1",
"class":"cell txt l",
"children":[
"Revascularization"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"ce7c80",
"class":"cell txt l",
"children":[
"Early endarterectomy or stenting is recommended after a nondisabling stroke or TIA if ipsilateral carotid stenosis is >70%, provided the patient is likely to live 5 years."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"39895a",
"class":"cell txt l",
"children":[
"Statins"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"31d687",
"class":"cell txt l",
"children":[
"High-intensity statin therapy is started for all patients regardless of cholesterol level."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"01da3e",
"class":"cell txt l",
"children":[
"Hypertension"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d7ea17",
"class":"cell txt l",
"children":[
"Maintain BP <130/80 mm Hg after recovery from the acute event."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"2c35c1",
"class":"cell txt l",
"children":[
"Glucose"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"d3ccd0",
"class":"cell txt l",
"children":[
"Intensive glucose control (80-130 mg/dL) does not improve stroke outcome compared with standard therapy (80-179 mg/dL)."
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"75cde5",
"class":"cell txt l",
"children":[
"Depression"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"17a456",
"class":"cell txt l",
"children":[
"Prevalent in the acute and chronic setting; identification and treatment improve recovery"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-8 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"51915f",
"class":"cell txt l",
"children":[
"Device closure of ",
{
"type":"abbreviation",
"title":"patent foramen ovale",
"children":[
"PFO"
]
},
" plus aspirin"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e5c0b6",
"class":"cell txt l",
"children":[
"To prevent second stroke in patients with PFO and no other cause of stroke"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}